Item 4 — Purpose of Transaction
On September 3, 2026, the Issuer entered into a stock purchase agreement with Frank A. Selden, as trustee of the Gratitude 2022 Trust, to purchase 8,693,290 shares of Common Stock (the "Purchased Shares") from the Trust. The purchase of the Purchased Shares will close subject to the satisfaction or waiver of customary closing conditions, including the accuracy of the parties' respective representations and warranties and compliance with the parties' respective covenants, as well as the satisfactory receipt by the Issuer's transfer agent of a duly executed stock transfer power, bearing a medallion signature guarantee, evidencing the transfer of the Purchased Shared to the Issuer. The purchase price for the Purchased Shares will be $3.68 per share, equal to the volume-weighted average price of the Issuer's common stock over the five trading days preceding the pricing date, less a 10% discount. The reporting persons acquired the shares of Common Stock of the Issuer for investment purposes. Subject to applicable securities laws and regulations, market conditions and other factors, the reporting persons may sell a portion of the shares of Common Stock beneficially owned by the reporting persons from time to time in open market transactions pursuant to Rule 144 under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to registered secondary offerings or transactions exempt from the registration requirements of the Securities Act, in privately negotiated transactions or otherwise, including pursuant to Rule 10b5-1 plans, for liquidity, asset diversification, tax and estate planning and charitable giving purposes. The reporting persons may modify their current plans depending on the reporting persons' evaluation of various factors, including the Issuer's business prospects and financial position, other developments concerning the Issuer, the price level of the Common Stock, conditions in the securities markets and general economic and industry conditions and other factors deemed relevant by the reporting persons. Furthermore, the reporting persons continue to reserve the right to formulate plans or make proposals, and take such action with respect thereto, including any or all of the items set forth in subsections (a) through (j) of Item 4 of Schedule 13D and any other actions, as they may determine.